Skip to content
GLP-1 Savers
Menu
Ranked #9 · Fair PriceEditorial review

Henry Meds review

The flat-fee pioneer: honest, no step-ups — just priced at the higher end of the market now.

Est. first month

$249/mo

Save ~82% vs brand-name
Get this deal Editorial review — no commercial relationship.
No teaser step-up. The flat-fee pioneer — honest and step-up-free, just priced at the higher end now.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only

The Value Score card

Henry Meds scored on our six published factors. See the methodology.

Lowest Real Price62/100
No Teaser-Rate Bait90/100
Nationwide Availability80/100
Both Molecules88/100
Easy Cancellation86/100
Reputation86/100

Why it's a deal

  • Simple flat-fee model with no teaser step-ups
  • Well-established brand
  • Both molecules

Read the fine print

  • Higher pricing than most newer entrants
  • Compounded only
  • Editorial pick — no affiliate relationship

The bottom line

Best for: People who want a simple, well-known flat-fee program and will pay a premium for it. The flat-fee pioneer: honest, no step-ups — just priced at the higher end of the market now.

Ranked #9 of 9 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

All 8 other programs we track, by Value Score.

Pricing, states and verification reflect Henry Meds's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to all deals